요 세포검사의 최근 검사기법 = New Techniques for the Detection of the Malignant Cells in Urine Cytology

다국어 초록 (Multilingual Abstract)

Transitional cell carcinoma of the urinary bladder is common in the genitourinary tract. The gold standard for the diagnosis of bladder cancer has been cystoscopy, along with urine cytology. Cystoscopy is an invasive and relatively expensive technique. By comparison, urine cytology is easy to perform and specific for a diagnosis of bladder cancer, although less sensitive, especially in low-grade tumors. For this reason, there has been a need for superior noninvasive technology to increase our confidence in being able to detect bladder cancer. There are many reports of the various urinary tests that are available to facilitate the diagnosis. In this article, I reviewed the literature on urinary markers and tests that may be clinically useful, including fluorescence in situ hybridization, uCyt+/Immunocyte, the $BTA^{(R)}$ test, the NMP 22TM, the $FDP^{(R)}$ test, the telomerase activity test, the HA and HAse tests, and flow cytometry. Most of these tests have a higher sensitivity and specificity than cytology. However, urine cytology has the highest specificity, especially in individuals with a high-grade tumor. We conclude that no urinary markers or tests can replace the role of cystoscopy along with cytology in the diagnosis of transitional cell carcinoma of the bladder. However, some markers could be used adjunctively to increase the diagnostic accuracy during screening or during the postoperative follow-up examination of patients with bladder cancer.

참고문헌 (Reference)

1 "Vysis UroVysion for the detection of urothelial carcinoma" 3 : 507-519, 2003

2 "Utilization of nuclear matrix proteins for cancer diagnosis" 6 : 189-214, 1996

3 "Utility of nuclear matrix protein in the detection of recurrent bladder cancer" 27 : 47-51, 2000

4 "Urinary markers of bladder carcinoma" 340 : 57-65, 2004

5 "Tumor-derived hyaluronidase" 778-783, 1997

6 "Tumor- associated antigens as prognostic factors for recurrence in 382 patients with primary transitional cell carcinoma of the bladder" 1 : 1195-1202, 1995

7 "The use of the BTA Test in the detection of persistent or recurrent transitional-cell cancer of the bladder" 15 : 103-106, 1997

8 "The role of fluorescence in situ hybridization technologies in molecular diagnostics and disease management" 5 : 309-319, 2000

9 "The development of a multitarget multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine" 2 : 116-123, 2002

10 "Telomeres shorten during ageing of human fibroblasts" 345 : 458-460, 1999

11 "Telomerase activity in malignant and benign bladder conditions" 1 : 835-840, 1998

12 "Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma" 82 : 727-732, 1998

13 "Screening and monitoring for bladder cancer" 166 : 75-78, 2001

14 "Rapid detection of bladder cancer a comparative study of point of care tests" 158 : 2098-2101, 1997

15 "Quanticytkaryometric analysis of bladder washing for patients with superficial bladder cancer" 48 : 357-564, 1996

16 "Performance characteristics of a new monoclonal antibody test for bladder cancer" 4 : 400-405, 1997

17 "Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification" 1331-5, 1

18 "Noninvasive detection of bladder cancer with the BTA stat test" 161 : 443-446, 1999

19 "Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings" 116 : 79-86, 2001

20 "Multicenter trial of the quantitative BTA TRAK assay in the detection of bladder cancer" 45 : 472-477, 1999

21 "Molecular genetics and biochemical mechanisms in bladder cancer" tumor suppressor genes 629-39,

22 "Molecular detection of primary bladder cancer by microsatellite analysis" 659-662, 1996

23 "Microsatellite analysis--DNA test in urine competes with cystoscopy in follow-up of superficial bladder carcinoma" 92 : 768-775, 2001

24 "Initial evaluation of the diagnostic performance of the new urinary bladder cancer antigen test as a tumor marker for transitional cell carcinoma of the bladder" 161 : 1110-1115, 1997

25 "Improved detection of recurrent bladder cancer using the Bard BTA stat Test" 50 : 349-353, 1997

26 "Immunocyt test improves the diagnostic accuracy of urinary cytology" 169 : 921-924, 2003

27 "ImmunoCyt/uCyt+ improves the sensitivity of urine cytology in patients followed for urothelial carcinoma" 18 : 83-89, 2005

28 "Identification of a nuclear protein matrix" 1410-7,

29 "HA-HAase urine test" 27 : 53-61, 2000

30 "Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma" 82 : 349-354, 1998

31 "Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma" 94 : 2914-2922, 2002

32 "Evaluation of two new urinary tumor markers bladder tumor fibronectin and cytokeratin 18 for the diagnosis of bladder cancer" 6 : 3585-3594, 2000

33 "Evaluation of the telomeric repeat amplification protocol assay for telomerase as a diagnostic modality in recurrent bladder cancer" 3 : 1593-1598, 1997

34 "Effect of intravesical instillation on performance of uCYT+ test" 63 : 878-881, 2004

35 "Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine" 158 : 1491-1502, 2001

36 "Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity" 82 : 708-714, 1998

37 "Cytokeratin 20 in human carcinomas A new histodiagnostic marker detected by monoclonal antibodies" 427-47, amjpathol1992

38 "Current concepts in biomarker technology for bladder cancers" 46 : 595-605, 2000

39 "Clinical significance of negative and equivocal urinary bladder cytology alone and in combination with DNA image analysis and cystoscopy" 81 : 354-364, 1997

40 "Clinical evaluation of the BTA TRAK assay and comparison to voided urine cytology and the Bard BTA test in patients with recurrent bladder tumors" 50 : 882-887, 1997

41 "Blood group-related antigens in human urothelium enhanced expression of precursor and LeY determinants in urothelial carcinoma" 4113-20,

42 "Annual Report of Cancer Registry Program in Republic of Korea" 2002

43 "Aberrant glycosylation in cancer cell membranes as focused on glycolipids" 2405-14,

44 "A multicenter trial evaluation of the fibrin/fibrinogen degradation products test for detection and monitoring of bladder cancer" 158 : 801-805, 1997

45 "A diagnostic-prognostic test for bladder cancer using a monoclonal antibody-based enzyme-linked immunoassay for detection of urinary fibrin" 5886-93,

46 "A diagnostic procedure in cancers of the urinary tract" 519-21, science1945

47 "A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma" 164 : 1768-1775, 2000